FibroBiologics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $554 | $0 |
Gross Profit | -206 | 277 | ||
EBITDA | -4,452 | -4,805 | -2,940 | -352 |
EBIT | -4,658 | -4,966 | -3,093 | -495 |
Net Income | -4,658 | -4,966 | -3,099 | -500 |
Net Change In Cash | 0 | 0 | 554 | 0 |
Free Cash Flow | -4,197 | -5,318 | -3,172 | -2,617 |
Cash | 8,845 | 8,667 | 13,985 | 7,827 |
Basic Shares | 38,635 | 36,673 | 32,875 | 33,516 |
Annual Financials
| Values in thousands | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -573 | -437 | -94 | |
EBITDA | -13,737 | -15,901 | -4,373 | -1,578 |
EBIT | -14,310 | -16,338 | -4,467 | |
Net Income | -11,161 | -16,485 | -5,121 | -1,582 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -12,085 | -6,896 | -4,066 | -1,410 |
Cash | 13,985 | 9,163 | 2,266 | 407 |
Basic Shares | 32,875 | 28,230 | 32,492 | 32,492 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.12 |
2025-03-31 | -$0.14 |
2024-12-31 | -$0.09 |
